Skip to main content
usedby

Who uses Owkin?

AI agent that connects multimodal patient data to biopharma research and clinical decisions. owkin.com

5

companies use Owkin

1 confirmed 4 observed

5 companies use Owkin. 60% are in Biotech & Pharma. Confirmed or observed customers include AstraZeneca, Cleveland Clinic Abu Dhabi, and Boehringer Ingelheim. 1 of them is confirmed by a published case study, quote or press release.Latest check Oct 8, 2026: 5 of 5 companies checked, from 3 public sources.

Customers by proof
1 confirmed, 4 observed
Top industry
Biotech & Pharma, 60% of customers
Website
owkin.com

What Owkin does

K Pro is Owkin's AI agent for pharmaceutical and biotech teams making decisions across drug development. It is trained and validated on multimodal patient data, with findings tested in wet labs and reviewed by oncologists and biologists. It generates multi-omic reports and helps explore hypotheses in minutes.

Written by usedby from owkin.com.

Main features

  • Multi-omic report generation
  • Autopilot mode
  • Real-time hypothesis exploration
  • Clinical research support

Common uses

  • Clinical trial decisions
  • Patient and population decisions
  • Early portfolio decisions

5 companies use Owkin

Every company below links to the public page that shows it uses Owkin. Open a row to see the dated capture.

Customers over time: appears once we have six months of archived captures.

CompanyIndustryProof
AstraZenecaBiotech & Pharma
Cleveland Clinic Abu Dhabi—
Boehringer Ingelheim—
Bristol Myers SquibbBiotech & Pharma
SanofiBiotech & Pharma
Showing 5 of 5.

By industry

60% of Owkin's customers are in Biotech & Pharma.

Biotech & Pharma3
Other2

What customers report

Results as published by Owkin and its customers. Each one links to its dated source. We quote, we do not score.

1,700CCAD prostate cancer patients' data integrated

Cleveland Clinic Abu Dhabi
Vendor case studyPublished Jul 10, 2026

Before you buy Owkin

What Owkin publishes on the points buyers check first, each with its source and check date.

Not verified yetWe have not yet verified Owkin's pricing, security or data terms.

Questions to ask in your demo

  1. Which of your customers look like us, by industry and size?
  2. What does a pilot cost, and what decides the move to a full contract?
  3. Where is our data stored, who can access it, and is it used to train models?
  4. How does Owkin work with the tools we already use?

Owkin alternatives

No comparison yetNo tool shares enough public customers with Owkin for a fair comparison yet.

Questions about Owkin

Who uses Owkin?

5 companies use Owkin, including AstraZeneca, Cleveland Clinic Abu Dhabi, and Boehringer Ingelheim.

Which industries use Owkin?

The industries with the most Owkin customers are Biotech & Pharma (3).

How does usedby know who uses Owkin?

Each company is linked to a public page that names it: Owkin's customer page, a published case study, a press release or a job post. We save each page with a dated capture and check it again on each run. A company leaves the list only after three checks in a row that no longer find it, and at least 14 days after it was last seen. A company with a published case study or quote is never removed automatically.

What do confirmed, observed and signal mean?

Confirmed (1): a case study, a named quote or a press release. Observed (4): Owkin shows the company on its own pages, for example a logo wall. Signal (0): a job post shows the company’s employees use Owkin, the weakest proof. Every level counts as a customer, and each line shows its level.

How current is this list?

The most recent check was on October 8, 2026, and 5 of 5 companies on this list have been checked so far. A company leaves the list only after three checks in a row that no longer find it, and at least 14 days after it was last seen. A company with a published case study or quote is never removed automatically.

Changes and sources

New customers

We have not started tracking changes for this tool yet.

Where this data comes from

Customer page owkin.com/case-studiesCaptured Oct 8, 2026
2 case studies, quotes and press releasesLatest capture Oct 8, 2026